These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Synthesis and antibacterial activities of 4-pyrrolidinylthio carbapenems: containing heteroaromatics as a side chain. Cho HW; Oh CH; Lee JS; Lee SC; Choi JH; Cho JH Arch Pharm (Weinheim); 2003 Nov; 336(11):495-503. PubMed ID: 14639741 [TBL] [Abstract][Full Text] [Related]
26. SM-216601, a novel parenteral 1beta-methylcarbapenem: structure-activity relationships of antibacterial activity and neurotoxicity in mice. Ueda Y; Itoh M; Sasaki A; Sunagawa M J Antibiot (Tokyo); 2005 Feb; 58(2):118-40. PubMed ID: 15835724 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel 1beta-methylcarbapenems having a new moiety at C-2. Kang YK; Shin KJ; Yoo KH; Seo KJ; Park SY; Kim DJ; Park SW Bioorg Med Chem Lett; 1999 Aug; 9(16):2385-90. PubMed ID: 10476874 [TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem. Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and antibacterial activity of 1beta-methyl-2-[5-(1,2-disubstituted ethyl)pyrrolidin-3-ylthio]carbapenem derivatives. Ahn SH; Jeon H; Choi JH; Baek D; Seo SH; Cho JH; Oh CH Arch Pharm (Weinheim); 2006 Feb; 339(2):67-73. PubMed ID: 16429454 [TBL] [Abstract][Full Text] [Related]
30. New penem compounds with 5'-substituted pyrrolidinylthio group as a C-2 side chain; comparison of their biological properties with those of carbapenem compounds. Sunagawa M; Matsumura H; Inoue T; Fukasawa M J Antibiot (Tokyo); 1992 Apr; 45(4):500-4. PubMed ID: 1592682 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem derivatives. Oh CH; Dong HG; Lee JS; Lee SC; Hong JH; Cho JH Arch Pharm (Weinheim); 2003 Dec; 336(12):567-72. PubMed ID: 14677150 [TBL] [Abstract][Full Text] [Related]
33. Novel C-2 substituted carbapenem derivatives. Part IV. Synthesis and biological activity of five membered heteroaromatic derivatives. Branch CL; Burton G; Clarke GJ; Coulton S; Douglas JD; Eglington AJ; Guest AW; Hinks JD; Hird NW; Holland RK; Hunt E; Knott SJ; Moss SF; Naylor A; Pearson MJ; Takle AK J Antibiot (Tokyo); 1998 Feb; 51(2):210-20. PubMed ID: 9544943 [TBL] [Abstract][Full Text] [Related]
34. Antibacterial properties of BO-2727, a new carbapenem antibiotic. Kato Y; Otsuki M; Nishino T J Antimicrob Chemother; 1997 Aug; 40(2):195-203. PubMed ID: 9301984 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological properties of new 1beta-methylcarbapenems containing heteroaromatic thioether moiety. Shin KJ; Koo KD; Yoo KH; Kang YK; Park SW; Kim DJ Bioorg Med Chem Lett; 2001 Sep; 11(17):2397-9. PubMed ID: 11527740 [TBL] [Abstract][Full Text] [Related]
36. In vitro antimicrobial activity and structure-activity relationship of C-2 triazolylthio and pyridinylmethylthio carbapenems. Fiakpui C; Thomas G; Singh MP; Micetich RG; Singh R J Antibiot (Tokyo); 1996 Feb; 49(2):212-5. PubMed ID: 8621364 [No Abstract] [Full Text] [Related]
37. Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems. Shinagawa H; Yamaga H; Houchigai H; Sumita Y; Sunagawa M Bioorg Med Chem; 1997 Mar; 5(3):601-21. PubMed ID: 9113338 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834. Miyauchi M; Endo R; Hisaoka M; Yasuda H; Kawamoto I J Antibiot (Tokyo); 1997 May; 50(5):429-39. PubMed ID: 9207914 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems Part IV. 2-Alkyl substituents containing cationic heteroaromatics linked via a C-C bond. Zam HA; Barrett D; Tanaka A; Sasaki H; Matsuda K; Sakurai M; Terasawa T; Shirai F; Chiba T; Matsumoto Y; Tawara S Bioorg Med Chem; 2001 Apr; 9(4):961-82. PubMed ID: 11354680 [TBL] [Abstract][Full Text] [Related]
40. New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems. Sunagawa M; Itoh M; Kubota K; Sasaki A; Ueda Y; Angehrn P; Bourson A; Goetschi E; Hebeisen P; Then RL J Antibiot (Tokyo); 2002 Aug; 55(8):722-57. PubMed ID: 12374386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]